{"product_id":"retatrutide","title":"Retatrutide","description":"\u003ch3 class=\"PDq2pG_selectionAnchorContainer\"\u003eWhat it is\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp\u003eA \u003cstrong\u003etriple hormone receptor agonist\u003c\/strong\u003e that activates:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eGLP-1 receptors\u003c\/li\u003e\n\u003cli\u003eGIP receptors\u003c\/li\u003e\n\u003cli\u003eGlucagon receptors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt's currently in Phase III clinical trials by Eli Lilly.\u003c\/p\u003e\n\u003ch3\u003eHow it works\u003c\/h3\u003e\n\u003cp\u003eUnlike Ozempic (GLP-1 only) or Tirzepatide (GLP-1 + GIP), Retatrutide activates all three systems.\u003c\/p\u003e\n\u003cp class=\"\"\u003eThis causes:\u003c\/p\u003e\n\u003cp\u003e• Appetite suppression\u003cbr\u003e• Slower stomach emptying\u003cbr\u003e• Increased insulin sensitivity\u003cbr\u003e• Increased calorie burning\u003cbr\u003e• Increased fat oxidation\u003c\/p\u003e\n\u003cp class=\"PDq2pG_selectionAnchorContainer\"\u003eThe glucagon component actually raises energy expenditure, which is one reason it has shown greater weight loss than earlier GLP-1 drugs. \u003cspan class=\"\"\u003e\u003c\/span\u003e\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003ePotential benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eSignificant fat loss\u003c\/li\u003e\n\u003cli\u003eBetter blood sugar control\u003c\/li\u003e\n\u003cli\u003eLower food cravings\u003c\/li\u003e\n\u003cli\u003ePossible improvements in fatty liver disease\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Chimera Research Labs","offers":[{"title":"Default Title","offer_id":48759288856825,"sku":null,"price":180.0,"currency_code":"USD","in_stock":false}],"url":"https:\/\/chimeraresearchlabs.com\/products\/retatrutide","provider":"Chimera Research Labs","version":"1.0","type":"link"}